Gary W. Miller - Publications

2002-2018 Emory University, Atlanta, GA 
 2018- Columbia University, New York, NY 
dopamine, Parkinsons disease

142 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Vermeulen R, Schymanski EL, Barabási AL, Miller GW. The exposome and health: Where chemistry meets biology. Science (New York, N.Y.). 367: 392-396. PMID 31974245 DOI: 10.1126/science.aay3164  1
2020 Branco RC, Burkett JP, Black CA, Winokur E, Elsworth W, Dhamsania RK, Lohr KM, Schroeder JP, Weinshenker D, Jovanovic T, Miller GW. Vesicular monoamine transporter 2 mediates fear behavior in mice. Genes, Brain, and Behavior. e12634. PMID 31898856 DOI: 10.1111/gbb.12634  1
2019 Niedzwiecki MM, Walker DI, Howell JC, Watts KD, Jones DP, Miller GW, Hu WT. High-resolution metabolomic profiling of Alzheimer's disease in plasma. Annals of Clinical and Translational Neurology. PMID 31828981 DOI: 10.1002/acn3.50956  1
2019 Walker DI, Valvi D, Rothman N, Lan Q, Miller GW, Jones DP. The metabolome: A key measure for exposome research in epidemiology. Current Epidemiology Reports. 6: 93-103. PMID 31828002  1
2019 Jin R, McConnell R, Catherine C, Xu S, Walker DI, Stratakis N, Jones DP, Miller GW, Peng C, Conti DV, Vos MB, Chatzi L. Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach. Environment International. 105220. PMID 31744629 DOI: 10.1016/j.envint.2019.105220  1
2019 Cheung AC, Walker DI, Juran BD, Miller GW, Lazaridis KN. Studying the Exposome to Understand the Environmental Determinants of Complex Liver Diseases. Hepatology (Baltimore, Md.). PMID 31701542 DOI: 10.1002/hep.31028  1
2019 Rampoldi A, Singh M, Wu Q, Duan M, Jha R, Maxwell JT, Bradner JM, Zhang X, Saraf A, Miller GW, Gibson G, Brown LA, Xu C. Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Toxicological Sciences : An Official Journal of the Society of Toxicology. 169: 280-292. PMID 31059573 DOI: 10.1093/toxsci/kfz038  1
2019 Manvich DF, Petko AK, Branco RC, Foster SL, Porter-Stransky KA, Stout KA, Newman AH, Miller GW, Paladini CA, Weinshenker D. Selective D and D receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30879021 DOI: 10.1038/s41386-019-0371-2  1
2019 Walker DI, Marder ME, Yano Y, Terrell M, Liang Y, Barr DB, Miller GW, Jones DP, Marcus M, Pennell KD. Multigenerational metabolic profiling in the Michigan PBB registry. Environmental Research. 172: 182-193. PMID 30782538 DOI: 10.1016/j.envres.2019.02.018  1
2018 Ladva CN, Golan R, Liang D, Greenwald R, Walker DI, Uppal K, Raysoni AU, Tran V, Yu T, Flanders WD, Miller GW, Jones DP, Sarnat JA. Particulate metal exposures induce plasma metabolome changes in a commuter panel study. Plos One. 13: e0203468. PMID 30231074 DOI: 10.1371/journal.pone.0203468  1
2018 Niedzwiecki MM, Walker DI, Vermeulen R, Chadeau-Hyam M, Jones DP, Miller GW. The Exposome: Molecules to Populations. Annual Review of Pharmacology and Toxicology. PMID 30095351 DOI: 10.1146/annurev-pharmtox-010818-021315  1
2018 Steves AN, Turry A, Gill B, Clarkson-Townsend D, Bradner JM, Bachli I, Caudle WM, Miller GW, Chan AWS, Easley CA. Per- and polyfluoroalkyl substances impact human spermatogenesis in a stem-cell-derived model. Systems Biology in Reproductive Medicine. 1-15. PMID 29911897 DOI: 10.1080/19396368.2018.1481465  1
2018 Steves AN, Bradner JM, Fowler KL, Clarkson-Townsend D, Gill BJ, Turry AC, Caudle WM, Miller GW, Chan AWS, Easley CA. Ubiquitous Flame-Retardant Toxicants Impair Spermatogenesis in a Human Stem Cell Model. Iscience. 3: 161-176. PMID 29901031 DOI: 10.1016/j.isci.2018.04.014  1
2018 Bhattacharya S, Ma Y, Dunn AR, Bradner JM, Scimemi A, Miller GW, Traynelis SF, Wichmann T. NMDA receptor blockade ameliorates abnormalities of spike firing of subthalamic nucleus neurons in a parkinsonian nonhuman primate. Journal of Neuroscience Research. PMID 29577359 DOI: 10.1002/jnr.24230  1
2018 Turner MC, Vineis P, Seleiro E, Dijmarescu M, Balshaw D, Bertollini R, Chadeau-Hyam M, Gant T, Gulliver J, Jeong A, Kyrtopoulos S, Martuzzi M, Miller GW, Nawrot T, Nieuwenhuijsen M, et al. EXPOsOMICS: final policy workshop and stakeholder consultation. Bmc Public Health. 18: 260. PMID 29448939 DOI: 10.1186/s12889-018-5160-z  1
2018 Niedzwiecki M, Samant P, Walker DI, Tran V, Jones DP, Prausnitz MR, Miller GW. Human suction blister fluid composition determined using high-resolution metabolomics. Analytical Chemistry. PMID 29425024 DOI: 10.1021/acs.analchem.7b04073  1
2017 Dunn AR, Hoffman CA, Stout KA, Ozawa M, Dhamsania RK, Miller GW. Immunochemical Analysis Of The Expression Of Sv2c In Mouse, Macaque And Human Brain. Brain Research. PMID 29274878 DOI: 10.1016/j.brainres.2017.12.029  1
2017 Niedzwiecki MM, Miller GW. The Exposome Paradigm in Human Health: Lessons from the Emory Exposome Summer Course. Environmental Health Perspectives. 125: 064502. PMID 28669935 DOI: 10.1289/EHP1712  1
2017 Dunn AR, Stout KA, Ozawa M, Lohr KM, Hoffman CA, Bernstein AI, Li Y, Wang M, Sgobio C, Sastry N, Cai H, Caudle WM, Miller GW. Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 28246328 DOI: 10.1073/pnas.1616892114  1
2016 Escher BI, Hackermüller J, Polte T, Scholz S, Aigner A, Altenburger R, Böhme A, Bopp SK, Brack W, Busch W, Chadeau-Hyam M, Covaci A, Eisenträger A, Galligan JJ, Garcia-Reyero N, ... ... Miller GW, et al. From the exposome to mechanistic understanding of chemical-induced adverse effects. Environment International. PMID 27939949 DOI: 10.1016/j.envint.2016.11.029  1
2016 Cliburn RA, Dunn AR, Stout KA, Hoffman CA, Lohr KM, Bernstein AI, Winokur EJ, Burkett J, Shmitz Y, Caudle WM, Miller GW. Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain. Journal of Chemical Neuroanatomy. PMID 27836486 DOI: 10.1016/j.jchemneu.2016.11.003  1
2016 Lohr KM, Masoud ST, Salahpour A, Miller GW. Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease. The European Journal of Neuroscience. PMID 27520881 DOI: 10.1111/ejn.13357  1
2016 Stout KA, Dunn AR, Lohr KM, Alter SP, Cliburn RA, Guillot TS, Miller GW. Selective enhancement of dopamine release in the ventral pallidum of methamphetamine-sensitized mice. Acs Chemical Neuroscience. PMID 27501345 DOI: 10.1021/acschemneuro.6b00131  1
2016 Lohr KM, Chen M, Hoffman CA, McDaniel MJ, Stout KA, Dunn AR, Wang M, Bernstein A, Miller GW. Vesicular monoamine transporter 2 (VMAT2) level regulates MPTP vulnerability and clearance of excess dopamine in mouse striatal terminals. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 27287315 DOI: 10.1093/toxsci/kfw106  1
2016 Dennis KK, Auerbach SS, Balshaw DM, Cui Y, Fallin MD, Smith MT, Spira A, Sumner S, Miller GW. The Importance of the Biological Impact of Exposure to the Concept of the Exposome. Environmental Health Perspectives. PMID 27258438 DOI: 10.1289/EHP140  1
2016 Farrell MS, McCorvy JD, Huang XP, Urban DJ, White KL, Giguere PM, Doak AK, Bernstein AI, Stout KA, Park SM, Rodriguiz RM, Gray BW, Hyatt WS, Norwood AP, Webster KA, ... ... Miller GW, et al. In Vitro and In Vivo Characterization of the Alkaloid Nuciferine. Plos One. 11: e0150602. PMID 26963248 DOI: 10.1371/journal.pone.0150602  1
2016 Trossbach SV, Bader V, Hecher L, Pum ME, Masoud ST, Prikulis I, Schäble S, de Souza Silva MA, Su P, Boulat B, Chwiesko C, Poschmann G, Stühler K, Lohr KM, Stout KA, ... ... Miller GW, et al. Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits. Molecular Psychiatry. PMID 26754951 DOI: 10.1038/mp.2015.194  1
2015 Alter SP, Stout KA, Lohr KM, Taylor TN, Shepherd KR, Wang M, Guillot TS, Miller GW. Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration. Experimental Neurology. PMID 26428905 DOI: 10.1016/j.expneurol.2015.09.016  1
2015 Go YM, Walker DI, Liang Y, Uppal K, Soltow QA, Tran V, Strobel F, Quyyumi AA, Ziegler TR, Pennell KD, Miller GW, Jones DP. Reference Standardization for Mass Spectrometry and High-resolution Metabolomics Applications to Exposome Research. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 26358001 DOI: 10.1093/toxsci/kfv198  1
2015 Liu G, Sgobio C, Gu X, Sun L, Lin X, Yu J, Parisiadou L, Xie C, Sastry N, Ding J, Lohr KM, Miller GW, Mateo Y, Lovinger DM, Cai H. Selective Expression of Parkinson's disease-related Leucine-rich Repeat Kinase 2 G2019S Missense Mutation in Midbrain Dopaminergic Neurons Impairs Dopamine Release and Dopaminergic Gene Expression. Human Molecular Genetics. PMID 26123485 DOI: 10.1093/hmg/ddv249  1
2015 Lohr KM, Stout KA, Dunn AR, Wang M, Salahpour A, Guillot TS, Miller GW. Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity. Acs Chemical Neuroscience. 6: 790-9. PMID 25746685 DOI: 10.1021/acschemneuro.5b00010  1
2015 Venter C, Miller GW. Toxicology at the speed of light: an interview with Dr. Craig Venter. Toxicological Sciences : An Official Journal of the Society of Toxicology. 144: 5-6. PMID 25721155 DOI: 10.1093/toxsci/kfv010  1
2015 Richardson JR, Taylor MM, Shalat SL, Guillot TS, Caudle WM, Hossain MM, Mathews TA, Jones SR, Cory-Slechta DA, Miller GW. Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 1960-72. PMID 25630971 DOI: 10.1096/fj.14-260901  1
2015 Miller GW. Data sharing in toxicology: beyond show and tell. Toxicological Sciences : An Official Journal of the Society of Toxicology. 143: 3-5. PMID 25538267 DOI: 10.1093/toxsci/kfu237  1
2015 Masoud ST, Vecchio LM, Bergeron Y, Hossain MM, Nguyen LT, Bermejo MK, Kile B, Sotnikova TD, Siesser WB, Gainetdinov RR, Wightman RM, Caron MG, Richardson JR, Miller GW, Ramsey AJ, et al. Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits. Neurobiology of Disease. 74: 66-75. PMID 25447236 DOI: 10.1016/j.nbd.2014.10.016  1
2014 Lohr KM, Miller GW. VMAT2 and Parkinson's disease: harnessing the dopamine vesicle. Expert Review of Neurotherapeutics. 14: 1115-7. PMID 25220836 DOI: 10.1586/14737175.2014.960399  1
2014 Lohr KM, Bernstein AI, Stout KA, Dunn AR, Lazo CR, Alter SP, Wang M, Li Y, Fan X, Hess EJ, Yi H, Vecchio LM, Goldstein DS, Guillot TS, Salahpour A, ... Miller GW, et al. Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo. Proceedings of the National Academy of Sciences of the United States of America. 111: 9977-82. PMID 24979780 DOI: 10.1073/pnas.1402134111  1
2014 Goldstein DS, Sullivan P, Holmes C, Miller GW, Sharabi Y, Kopin IJ. A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease. Journal of Neurochemistry. PMID 24848581 DOI: 10.1111/jnc.12766  1
2014 Gyoneva S, Shapiro L, Lazo C, Garnier-Amblard E, Smith Y, Miller GW, Traynelis SF. Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease. Neurobiology of Disease. 67: 191-202. PMID 24632419 DOI: 10.1016/j.nbd.2014.03.004  1
2014 Bernstein AI, Stout KA, Miller GW. The vesicular monoamine transporter 2: an underexplored pharmacological target. Neurochemistry International. 73: 89-97. PMID 24398404 DOI: 10.1016/j.neuint.2013.12.003  1
2014 Qi Z, Miller GW, Voit EO. Rotenone and paraquat perturb dopamine metabolism: A computational analysis of pesticide toxicity. Toxicology. 315: 92-101. PMID 24269752 DOI: 10.1016/j.tox.2013.11.003  1
2014 Miller GW, Jones DP. The nature of nurture: refining the definition of the exposome. Toxicological Sciences : An Official Journal of the Society of Toxicology. 137: 1-2. PMID 24213143 DOI: 10.1093/toxsci/kft251  1
2014 Taylor TN, Alter SP, Wang M, Goldstein DS, Miller GW. Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus. Neuropharmacology. 76: 97-105. PMID 24025942 DOI: 10.1016/j.neuropharm.2013.08.033  1
2013 Inamdar AA, Hossain MM, Bernstein AI, Miller GW, Richardson JR, Bennett JW. Fungal-derived semiochemical 1-octen-3-ol disrupts dopamine packaging and causes neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America. 110: 19561-6. PMID 24218591 DOI: 10.1073/pnas.1318830110  1
2013 Chen H, Burton EA, Ross GW, Huang X, Savica R, Abbott RD, Ascherio A, Caviness JN, Gao X, Gray KA, Hong JS, Kamel F, Jennings D, Kirshner A, Lawler C, ... ... Miller GW, et al. Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications. Environmental Health Perspectives. 121: 1245-52. PMID 23933572 DOI: 10.1289/ehp.1306967  1
2013 Goldstein DS, Sullivan P, Holmes C, Miller GW, Alter S, Strong R, Mash DC, Kopin IJ, Sharabi Y. Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease. Journal of Neurochemistry. 126: 591-603. PMID 23786406 DOI: 10.1111/jnc.12345  1
2013 Alter SP, Lenzi GM, Bernstein AI, Miller GW. Vesicular integrity in Parkinson's disease. Current Neurology and Neuroscience Reports. 13: 362. PMID 23690026 DOI: 10.1007/s11910-013-0362-3  1
2013 Pranski EL, Dalal NV, Sanford CV, Herskowitz JH, Gearing M, Lazo C, Miller GW, Lah JJ, Levey AI, Betarbet RS. RING finger protein 11 (RNF11) modulates susceptibility to 6-OHDA-induced nigral degeneration and behavioral deficits through NF-κB signaling in dopaminergic cells. Neurobiology of Disease. 54: 264-79. PMID 23318928 DOI: 10.1016/j.nbd.2012.12.018  1
2013 Bradner JM, Suragh TA, Wilson WW, Lazo CR, Stout KA, Kim HM, Wang MZ, Walker DI, Pennell KD, Richardson JR, Miller GW, Caudle WM. Exposure to the polybrominated diphenyl ether mixture DE-71 damages the nigrostriatal dopamine system: role of dopamine handling in neurotoxicity. Experimental Neurology. 241: 138-47. PMID 23287494 DOI: 10.1016/j.expneurol.2012.12.013  1
2013 Alter SP, Taylor TN, Sullivan P, Goldstein DS, Miller GW. Progressive Noradrenergic Degeneration in Mice with Reduced Expression of the Vesicular Monoamine Transporter (VMAT2) Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 125. DOI: 10.1016/B978-0-12-800044-1.00108-2  1
2013 Miller GW. Increased Catecholamine Toxicity in Mice with Low Expression of VMAT2 Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 62. DOI: 10.1016/B978-0-12-800044-1.00056-8  1
2013 Miller G. The Exposome: A Primer The Exposome: a Primer. 1-103.  1
2012 Hatcher-Martin JM, Gearing M, Steenland K, Levey AI, Miller GW, Pennell KD. Association between polychlorinated biphenyls and Parkinson's disease neuropathology. Neurotoxicology. 33: 1298-304. PMID 22906799 DOI: 10.1016/j.neuro.2012.08.002  1
2012 Caudle WM, Guillot TS, Lazo C, Miller GW. Parkinson's disease and the environment: beyond pesticides. Neurotoxicology. 33: 585. PMID 22774228 DOI: 10.1016/j.neuro.2012.04.011  1
2012 Dean ED, Mexas LM, Cápiro NL, McKeon JE, DeLong MR, Pennell KD, Doorn JA, Tangpricha V, Miller GW, Evatt ML. 25-Hydroxyvitamin D depletion does not exacerbate MPTP-induced dopamine neuron damage in mice. Plos One. 7: e39227. PMID 22768297 DOI: 10.1371/journal.pone.0039227  1
2012 Wang Y, Kim JH, Baek JB, Miller GW, Pennell KD. Transport behavior of functionalized multi-wall carbon nanotubes in water-saturated quartz sand as a function of tube length. Water Research. 46: 4521-31. PMID 22704927 DOI: 10.1016/j.watres.2012.05.036  1
2012 Bernstein AI, Stout KA, Miller GW. A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transport. Journal of Neuroscience Methods. 209: 357-66. PMID 22698664 DOI: 10.1016/j.jneumeth.2012.06.002  1
2012 Caudle WM, Guillot TS, Lazo CR, Miller GW. Industrial toxicants and Parkinson's disease. Neurotoxicology. 33: 178-88. PMID 22309908 DOI: 10.1016/j.neuro.2012.01.010  1
2012 Qi Z, Miller GW, Voit EO. Mathematical models of dopamine metabolism in parkinson’s disease Systems Biology of Parkinson's Disease. 151-171. DOI: 10.1007/978-1-4614-3411-5_8  1
2011 Taylor TN, Caudle WM, Miller GW. VMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease. Parkinson's Disease. 2011: 124165. PMID 21403896 DOI: 10.4061/2011/124165  1
2011 She H, Yang Q, Shepherd K, Smith Y, Miller G, Testa C, Mao Z. Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients. The Journal of Clinical Investigation. 121: 930-40. PMID 21393861 DOI: 10.1172/JCI43871  1
2010 Qi Z, Miller GW, Voit EO. Computational modeling of synaptic neurotransmission as a tool for assessing dopamine hypotheses of schizophrenia. Pharmacopsychiatry. 43: S50-60. PMID 20486051 DOI: 10.1055/s-0030-1248317  1
2010 Qi Z, Miller GW, Voit EO. The internal state of medium spiny neurons varies in response to different input signals. Bmc Systems Biology. 4: 26. PMID 20236543 DOI: 10.1186/1752-0509-4-26  1
2010 Bernstein AI, Miller GW. Oxidative signaling in experimental autoimmune encephalomyelitis. Toxicological Sciences : An Official Journal of the Society of Toxicology. 114: 159-61. PMID 20234054 DOI: 10.1093/toxsci/kfq012  1
2010 Taylor TN, Greene JG, Miller GW. Behavioral phenotyping of mouse models of Parkinson's disease. Behavioural Brain Research. 211: 1-10. PMID 20211655 DOI: 10.1016/j.bbr.2010.03.004  1
2010 Jang SW, Liu X, Yepes M, Shepherd KR, Miller GW, Liu Y, Wilson WD, Xiao G, Blanchi B, Sun YE, Ye K. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proceedings of the National Academy of Sciences of the United States of America. 107: 2687-92. PMID 20133810 DOI: 10.1073/pnas.0913572107  1
2009 McCall IC, Betanzos A, Weber DA, Nava P, Miller GW, Parkos CA. Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization. Toxicology and Applied Pharmacology. 241: 61-70. PMID 19679145 DOI: 10.1016/j.taap.2009.08.002  1
2009 Qi Z, Miller GW, Voit EO. Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals. Synapse (New York, N.Y.). 63: 1133-42. PMID 19670315 DOI: 10.1002/syn.20686  1
2009 Taylor TN, Caudle WM, Shepherd KR, Noorian A, Jackson CR, Iuvone PM, Weinshenker D, Greene JG, Miller GW. Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 8103-13. PMID 19553450 DOI: 10.1523/JNEUROSCI.1495-09.2009  1
2009 Guillot TS, Miller GW. Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons. Molecular Neurobiology. 39: 149-70. PMID 19259829 DOI: 10.1007/s12035-009-8059-y  1
2009 Wang J, Sharma BD, Li Y, Miller GW. Modeling and validating spatial patterns of a 3D stand generator for central Appalachian hardwood forests Computers and Electronics in Agriculture. 68: 141-149. DOI: 10.1016/j.compag.2009.05.005  0.64
2008 Guillot TS, Asress SA, Richardson JR, Glass JD, Miller GW. Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis. Journal of Motor Behavior. 40: 568-77. PMID 18980909 DOI: 10.3200/JMBR.40.6.568-577  1
2008 Qi Z, Miller GW, Voit EO. A mathematical model of presynaptic dopamine homeostasis: implications for schizophrenia. Pharmacopsychiatry. 41: S89-98. PMID 18756426 DOI: 10.1055/s-2008-1080936  1
2008 Voit EO, Qi Z, Miller GW. Steps of modeling complex biological systems. Pharmacopsychiatry. 41: S78-84. PMID 18756424 DOI: 10.1055/s-2008-1080911  1
2008 Guillot TS, Shepherd KR, Richardson JR, Wang MZ, Li Y, Emson PC, Miller GW. Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis. Journal of Neurochemistry. 106: 2205-17. PMID 18643795 DOI: 10.1111/j.1471-4159.2008.05568.x  1
2008 Richardson JR, Caudle WM, Wang MZ, Dean ED, Pennell KD, Miller GW. Developmental heptachlor exposure increases susceptibility of dopamine neurons to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)in a gender-specific manner. Neurotoxicology. 29: 855-63. PMID 18577399 DOI: 10.1016/j.neuro.2008.05.007  1
2008 Qi Z, Miller GW, Voit EO. Computational systems analysis of dopamine metabolism. Plos One. 3: e2444. PMID 18568086 DOI: 10.1371/journal.pone.0002444  1
2008 Jones DC, Miller GW. The effects of environmental neurotoxicants on the dopaminergic system: A possible role in drug addiction. Biochemical Pharmacology. 76: 569-81. PMID 18555207 DOI: 10.1016/j.bcp.2008.05.010  1
2008 Hatcher JM, Delea KC, Richardson JR, Pennell KD, Miller GW. Disruption of dopamine transport by DDT and its metabolites. Neurotoxicology. 29: 682-90. PMID 18533268 DOI: 10.1016/j.neuro.2008.04.010  1
2008 Guillot TS, Richardson JR, Wang MZ, Li YJ, Taylor TN, Ciliax BJ, Zachrisson O, Mercer A, Miller GW. PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity. Neuropeptides. 42: 423-34. PMID 18533255 DOI: 10.1016/j.npep.2008.04.003  1
2008 Caudle WM, Colebrooke RE, Emson PC, Miller GW. Altered vesicular dopamine storage in Parkinson's disease: a premature demise. Trends in Neurosciences. 31: 303-8. PMID 18471904 DOI: 10.1016/j.tins.2008.02.010  1
2008 Hatcher JM, Pennell KD, Miller GW. Parkinson's disease and pesticides: a toxicological perspective. Trends in Pharmacological Sciences. 29: 322-9. PMID 18453001 DOI: 10.1016/  1
2008 Miller GW. Paraquat and parkinson's disease: Response by Dr. Miller, Part II Toxicological Sciences. 103: 222-223. DOI: 10.1093/toxsci/kfn029  1
2008 Miller GW. Paraquat and parkinson's disease: Response by Dr. Miller Toxicological Sciences. 103: 217-218. DOI: 10.1093/toxsci/kfm310  1
2008 Hatcher JM, Jones DP, Miller GW, Pennell KD. Neurotoxicity of Manufactured Nanoparticles Nanoscience and Nanotechnology: Environmental and Health Impacts. 405-428. DOI: 10.1002/9780470396612.ch16  1
2007 Miller GW. Paraquat: the red herring of Parkinson's disease research. Toxicological Sciences : An Official Journal of the Society of Toxicology. 100: 1-2. PMID 17934192 DOI: 10.1093/toxsci/kfm223  1
2007 Rommelfanger KS, Edwards GL, Freeman KG, Liles LC, Miller GW, Weinshenker D. Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proceedings of the National Academy of Sciences of the United States of America. 104: 13804-9. PMID 17702867 DOI: 10.1073/pnas.0702753104  1
2007 Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormack AL, Colebrooke RE, Di Monte DA, Emson PC, Miller GW. Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8138-48. PMID 17652604 DOI: 10.1523/JNEUROSCI.0319-07.2007  1
2007 Hamill CE, Caudle WM, Richardson JR, Yuan H, Pennell KD, Greene JG, Miller GW, Traynelis SF. Exacerbation of dopaminergic terminal damage in a mouse model of Parkinson's disease by the G-protein-coupled receptor protease-activated receptor 1. Molecular Pharmacology. 72: 653-64. PMID 17596374 DOI: 10.1124/mol.107.038158  1
2007 Manning-Bo? AB, Caudle WM, Perez XA, Reaney SH, Paletzki R, Isla MZ, Chou VP, McCormack AL, Miller GW, Langston JW, Gerfen CR, Dimonte DA. Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter. Neurobiology of Disease. 27: 141-50. PMID 17560790 DOI: 10.1016/j.nbd.2007.03.014  1
2007 Hatcher JM, Richardson JR, Guillot TS, McCormack AL, Di Monte DA, Jones DP, Pennell KD, Miller GW. Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Experimental Neurology. 204: 619-30. PMID 17291500 DOI: 10.1016/j.expneurol.2006.12.020  1
2007 Sherer TB, Richardson JR, Testa CM, Seo BB, Panov AV, Yagi T, Matsuno-Yagi A, Miller GW, Greenamyre JT. Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease. Journal of Neurochemistry. 100: 1469-79. PMID 17241123 DOI: 10.1111/j.1471-4159.2006.04333.x  1
2007 Richardson JR, Caudle WM, Guillot TS, Watson JL, Nakamaru-Ogiso E, Seo BB, Sherer TB, Greenamyre JT, Yagi T, Matsuno-Yagi A, Miller GW. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicological Sciences : An Official Journal of the Society of Toxicology. 95: 196-204. PMID 17038483 DOI: 10.1093/toxsci/kfl133  1
2007 Ramachandiran S, Hansen JM, Jones DP, Richardson JR, Miller GW. Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. Toxicological Sciences : An Official Journal of the Society of Toxicology. 95: 163-71. PMID 17018646 DOI: 10.1093/toxsci/kfl125  1
2007 Caudle WM, Tillerson JL, Reverón ME, Miller GW. Use-dependent behavioral and neurochemical asymmetry in MPTP mice. Neuroscience Letters. 418: 213-6. PMID 16603316 DOI: 10.1016/j.neulet.2006.03.045  1
2006 Savelieva KV, Caudle WM, Miller GW. Altered ethanol-associated behaviors in vesicular monoamine transporter heterozygote knockout mice. Alcohol (Fayetteville, N.Y.). 40: 87-94. PMID 17307644 DOI: 10.1016/j.alcohol.2006.09.030  1
2006 Richardson JR, Caudle WM, Wang M, Dean ED, Pennell KD, Miller GW. Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 1695-7. PMID 16809432 DOI: 10.1096/fj.06-5864fje  1
2006 Tillerson JL, Caudle WM, Parent JM, Gong C, Schallert T, Miller GW. Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor. Behavioural Brain Research. 172: 97-105. PMID 16765459 DOI: 10.1016/j.bbr.2006.04.025  1
2006 Caudle WM, Richardson JR, Delea KC, Guillot TS, Wang M, Pennell KD, Miller GW. Polychlorinated biphenyl-induced reduction of dopamine transporter expression as a precursor to Parkinson's disease-associated dopamine toxicity. Toxicological Sciences : An Official Journal of the Society of Toxicology. 92: 490-9. PMID 16702228 DOI: 10.1093/toxsci/kfl018  1
2006 Elwan MA, Richardson JR, Guillot TS, Caudle WM, Miller GW. Pyrethroid pesticide-induced alterations in dopamine transporter function. Toxicology and Applied Pharmacology. 211: 188-97. PMID 16005927 DOI: 10.1016/j.taap.2005.06.003  1
2005 Richardson JR, Quan Y, Sherer TB, Greenamyre JT, Miller GW. Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicological Sciences : An Official Journal of the Society of Toxicology. 88: 193-201. PMID 16141438 DOI: 10.1093/toxsci/kfi304  1
2005 Caudle WM, Richardson JR, Wang M, Miller GW. Perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum. Neurotoxicology. 26: 721-8. PMID 16112329 DOI: 10.1016/j.neuro.2004.09.003  1
2005 Wang X, Li Y, Engisch KL, Nakanishi ST, Dodson SE, Miller GW, Cope TC, Pinter MJ, Rich MM. Activity-dependent presynaptic regulation of quantal size at the mammalian neuromuscular junction in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 343-51. PMID 15647477 DOI: 10.1523/JNEUROSCI.3252-04.2005  1
2004 Rommelfanger KS, Weinshenker D, Miller GW. Reduced MPTP toxicity in noradrenaline transporter knockout mice. Journal of Neurochemistry. 91: 1116-24. PMID 15569255 DOI: 10.1111/j.1471-4159.2004.02785.x  1
2004 Richardson JR, Miller GW. Acute exposure to aroclor 1016 or 1260 differentially affects dopamine transporter and vesicular monoamine transporter 2 levels. Toxicology Letters. 148: 29-40. PMID 15019086 DOI: 10.1016/j.toxlet.2003.12.006  1
2003 Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT. Mechanism of toxicity in rotenone models of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 10756-64. PMID 14645467  1
2003 Tillerson JL, Caudle WM, Reverón ME, Miller GW. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease. Neuroscience. 119: 899-911. PMID 12809709 DOI: 10.1016/S0306-4522(03)00096-4  1
2003 Decker MJ, Hue GE, Caudle WM, Miller GW, Keating GL, Rye DB. Episodic neonatal hypoxia evokes executive dysfunction and regionally specific alterations in markers of dopamine signaling. Neuroscience. 117: 417-25. PMID 12614682 DOI: 10.1016/S0306-4522(02)00805-9  1
2003 Tillerson JL, Miller GW. Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism. Journal of Neuroscience Methods. 123: 189-200. PMID 12606067 DOI: 10.1016/S0165-0270(02)00360-6  1
2002 Tillerson JL, Miller GW. Forced limb-use and recovery following brain injury. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 8: 574-85. PMID 12467379 DOI: 10.1177/1073858402238516  1
2002 Tillerson JL, Caudle WM, Reverón ME, Miller GW. Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Experimental Neurology. 178: 80-90. PMID 12460610 DOI: 10.1006/exnr.2002.8021  1
2002 Metzger RR, Brown JM, Sandoval V, Rau KS, Elwan MA, Miller GW, Hanson GR, Fleckenstein AE. Inhibitory effect of reserpine on dopamine transporter function. European Journal of Pharmacology. 456: 39-43. PMID 12450567 DOI: 10.1016/S0014-2999(02)02647-X  1
2002 Reveron ME, Savelieva KV, Tillerson JL, McCormack AL, Di Monte DA, Miller GW. L-DOPA does not cause neurotoxicity in VMAT2 heterozygote knockout mice. Neurotoxicology. 23: 611-9. PMID 12428733 DOI: 10.1016/S0161-813X(02)00037-2  1
2002 Stephans SE, Miller GW, Levey AI, Greenamyre JT. Acute mitochondrial and chronic toxicological effects of 1-methyl-4-phenylpyridinium in human neuroblastoma cells. Neurotoxicology. 23: 569-80. PMID 12428729 DOI: 10.1016/S0161-813X(02)00060-8  1
2002 Tillerson JL, Cohen AD, Caudle WM, Zigmond MJ, Schallert T, Miller GW. Forced nonuse in unilateral parkinsonian rats exacerbates injury. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6790-9. PMID 12151559  1
2002 Savelieva KV, Caudle WM, Findlay GS, Caron MG, Miller GW. Decreased ethanol preference and consumption in dopamine transporter female knock-out mice. Alcoholism, Clinical and Experimental Research. 26: 758-64. PMID 12068242 DOI: 10.1097/00000374-200206000-00003  1
2002 Findlay GS, Wick MJ, Mascia MP, Wallace D, Miller GW, Harris RA, Blednov YA. Transgenic expression of a mutant glycine receptor decreases alcohol sensitivity of mice. The Journal of Pharmacology and Experimental Therapeutics. 300: 526-34. PMID 11805213 DOI: 10.1124/jpet.300.2.526  1
2001 Miller GW, Wang YM, Gainetdinov RR, Caron MG. Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease. Methods in Molecular Medicine. 62: 179-90. PMID 21318776 DOI: 10.1385/1-59259-142-6:179  1
2001 Miller GW, Levey AI. Immunochemical analysis of dopamine transporters in Parkinson's disease. Methods in Molecular Medicine. 62: 167-77. PMID 21318775 DOI: 10.1385/1-59259-142-6:167  1
2001 Tillerson JL, Cohen AD, Philhower J, Miller GW, Zigmond MJ, Schallert T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 4427-35. PMID 11404429  1
2001 Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG, Hen R. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proceedings of the National Academy of Sciences of the United States of America. 98: 1982-7. PMID 11172062 DOI: 10.1073/pnas.98.4.1982  1
2000 Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang YM, Caron MG. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nature Neuroscience. 3: 465-71. PMID 10769386 DOI: 10.1038/74839  1
1999 Miller GW, Kirby ML, Levey AI, Bloomquist JR. Heptachlor alters expression and function of dopamine transporters. Neurotoxicology. 20: 631-7. PMID 10499361  1
1999 Miller GW, Gainetdinov RR, Levey AI, Caron MG. Dopamine transporters and neuronal injury. Trends in Pharmacological Sciences. 20: 424-9. PMID 10498956 DOI: 10.1016/S0165-6147(99)01379-6  1
1999 Sarang SS, Miller GW, Grant DF, Schnellmann RG. Expression and localization of the neuronal glycine receptor beta-subunit in human, rabbit and rat kidneys. Nephron. 82: 254-60. PMID 10395998 DOI: 10.1159/000045410  1
1999 Ciliax BJ, Drash GW, Staley JK, Haber S, Mobley CJ, Miller GW, Mufson EJ, Mash DC, Levey AI. Immunocytochemical localization of the dopamine transporter in human brain. The Journal of Comparative Neurology. 409: 38-56. PMID 10363710 DOI: 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1  1
1999 Miller GW, Erickson JD, Perez JT, Penland SN, Mash DC, Rye DB, Levey AI. Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease. Experimental Neurology. 156: 138-48. PMID 10192785 DOI: 10.1006/exnr.1998.7008  1
1999 Fumagalli F, Gainetdinov RR, Wang YM, Valenzano KJ, Miller GW, Caron MG. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 2424-31. PMID 10087057  1
1998 Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW, Caron MG. Cocaine self-administration in dopamine-transporter knockout mice. Nature Neuroscience. 1: 132-7. PMID 10195128 DOI: 10.1038/381  1
1998 Miller GW, Gilmor ML, Levey AI. Generation of transporter-specific antibodies. Methods in Enzymology. 296: 407-22. PMID 9779463 DOI: 10.1016/S0076-6879(98)96029-3  1
1998 Gainetdinov RR, Fumagalli F, Wang YM, Jones SR, Levey AI, Miller GW, Caron MG. Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice. Journal of Neurochemistry. 70: 1973-8. PMID 9572281  1
1997 Waters SL, Miller GW, Aleo MD, Schnellmann RG. Neurosteroid inhibition of cell death. American Journal of Physiology. Renal Physiology. 273: F869-F876. PMID 29586117 DOI: 10.1152/ajprenal.1997.273.6.F869  1
1997 Waters SL, Miller GW, Aleo MD, Schnellmann RG. Neurosteroid inhibition of cell death. The American Journal of Physiology. 273: F869-76. PMID 9435674  1
1997 Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW, Wightman RM, Caron MG. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron. 19: 1285-96. PMID 9427251 DOI: 10.1016/S0896-6273(00)80419-5  1
1997 Subramanian T, Emerich DF, Bakay RA, Hoffman JM, Goodman MM, Shoup TM, Miller GW, Levey AI, Hubert GW, Batchelor S, Winn SR, Saydoff JA, Watts RL. Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates. Cell Transplantation. 6: 469-77. PMID 9331498 DOI: 10.1016/S0963-6897(97)00049-3  1
1997 Miller GW, Staley JK, Heilman CJ, Perez JT, Mash DC, Rye DB, Levey AI. Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Annals of Neurology. 41: 530-9. PMID 9124811 DOI: 10.1002/ana.410410417  1
1997 Staley JK, Talbot JZ, Ciliax BJ, Miller GW, Levey AI, Kung MP, Kung HF, Mash DC. Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic nerve terminals in human cocaine overdose victims. Brain Research. 747: 219-29. PMID 9045996 DOI: 10.1016/S0006-8993(96)01196-1  1
1995 Miller GW, Schnellmann RG. Inhibitors of renal chloride transport do not block toxicant-induced chloride influx in the proximal tubule. Toxicology Letters. 76: 179-84. PMID 7725349 DOI: 10.1016/0378-4274(94)03224-U  1
1994 Miller GW, Lock EA, Schnellmann RG. Strychnine and glycine protect renal proximal tubules from various nephrotoxicants and act in the late phase of necrotic cell injury. Toxicology and Applied Pharmacology. 125: 192-7. PMID 8171427 DOI: 10.1006/taap.1994.1064  1
1994 Miller GW, Schnellmann RG. A putative cytoprotective receptor in the kidney: relation to the neuronal strychnine-sensitive glycine receptor. Life Sciences. 55: 27-34. PMID 8015346 DOI: 10.1016/0024-3205(94)90078-7  1
1993 Miller GW, Schnellmann RG. Cytoprotection by inhibition of chloride channels: the mechanism of action of glycine and strychnine. Life Sciences. 53: 1211-5. PMID 8412478 DOI: 10.1016/0024-3205(93)90539-F  1
1993 Miller GW, Schnellmann RG. A novel low-affinity strychnine binding site on renal proximal tubules: role in toxic cell death. Life Sciences. 53: 1203-9. PMID 8412477 DOI: 10.1016/0024-3205(93)90538-E  1
Show low-probability matches.